Hepatitis C virus infection in a prison population. A prospective study in Loos-lez-Lille, France;Infection par le virus de l'hepatite C en milieu carceral: Etude prospective realisee a Loos-lez-Lille

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 1, 1998, Pages 55-58

  Hedouin, Valéry ^a   Gosset, Didier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Hepatitis C virus; Prison survey; Toxicomania

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FRANCE; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE; POPULATION RESEARCH; PREVALENCE; PRISON; PROSPECTIVE STUDY; RISK FACTOR; SYRINGE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; FRANCE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRISONS; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0031952754     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Roudot-Thoraval F. Epidémiologie des infections liées au virus de l'hépatite C en France. Bull Acad Natl Med 1996;180:1253-65.
2. Espinoza P, Bouchard I, Buffet C, Thiers V, Pillot J, Etienne JP. Forte prévalence de l'infection par le virus de l'hépatite B et le virus HIV chez les toxicomanes français incarcérés. Gastroenterol Clin Biol 1987;11:288-92.
3. Crofts N, Stewart T, Hearne P, Ping XY, Breschkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995;30:285-7.
4. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. Hepatitis C virus in intravenous drug users. Med J Aust 1990;153:274-6.
5. Donahue JG, Nelson KE, Munoz A, Vlahov D, Rennie LL, Taylor EL, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991;134:1206-11.
6. Fingerhood MI, Jasinski DR, Sullivan JT. Prevalence of hepatitis C in a chemically dependent population. Arch Intern Med 1993;153:2025-30.
7. Girardi E, Zaccarelli M, Tossini G, Puro V, Narciso P, Visco G. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis 1990;22:751-2.
8. Huemer HP, Prodinger WM, Larcher C, Most L, Dierich MP. Correlation of hepatitis C virus antibodies with HIV-1-seropositivity in intravenous drug addicts. Infection 1990;18:122-3.
9. Patti AM, Santi AL, Pompa MG, Giustini C, Vescia N, Mastroeni K, et al. Viral hepatitis and drugs: a continuing problem. Int J Epidemiol 1993;22:135-9.
10. Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993;9:255-62.
11. Van den Hoek JA, Van Haastrecht HJ, Goudsmit J, De Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990;162:823-6.
12. Zeldis JB, Jain S, Kuramoto IK. Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med 1992;156:30-5.
13. Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, et al. Antibodies to hepatitis C virus. Lancet 1989;2:324-5.
14. Esteban J, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzales A, Hernandez JM, et al. Hepatitis C virus antibiodies among risk groups in spain. Lancet 1989;2:294-7.
15. Mortimer PP, Cohen BJ, Litton PA, Vand der Velde EM, Bassendine MF, Brinde AM, et al. Hepatitis C virus antibody. Lancet 1989;2:798.
16. Kelen GD, Green GB, Purcell RH, Chan DW, Qaqish BF, Sivertson KT, et al. Hepatitis B and C in emergency department patients. N Engl J Med 1992;326:1399-404.
17. Thomas D, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine 1995;74:212-20.
18. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
19. Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes MC, Muyssen A, et al. Prévalence des marqueurs des hépatites C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveineux. Gastroenterol Clin Biol 1994;18:964-8.
20. Couzigou P. Sexe, famille et virus de l'hépatite C. Association prouvée, causalité non établie. Gastroenterol Clin Biol 1995;19:147-9.
21. David XR, Blanc P, Pageaux GP, Desprez D, Diaz D, Lemaire JM, et al. Transmission familiale du virus de l'hépatite C. Gastroenterol Clin Biol 1995;19:150-5.
22. Serfaty L, Mavier P, Valla D. Quels sont les modes de transmission non transfusionnels du virus de l'hépatite C ? Gastroenterol Clin Biol 1995;19:525-33.
23. Conférence de Consensus. Hépatite C: dépistage et traitement. Gastroenterol Clin Biol 1997;21 (Suppl. 1 bis).
24. Cantilena CC, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.